BL Salomon, M Leclerc, J Tosello, E Ronin… - Frontiers in …, 2018 - frontiersin.org
Tumor necrosis factor α (TNF) is a potent pro-inflammatory cytokine that has deleterious effect in some autoimmune diseases, which led to the use of anti-TNF drugs in some of …
Acute graft-versus-host disease (aGVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (alloHCT) and is a major cause of morbidity and …
MA Schroeder, HJ Khoury, M Jagasia, H Ali… - Blood …, 2020 - ashpublications.org
Acute graft-versus-host disease (aGVHD) following allogeneic hematopoietic cell transplantation (HCT) is a primary cause of nonrelapse mortality and a major barrier to …
Allogeneic hematopoietic cell transplantation (allo-HCT) can be curative in patients with hematologic malignancies but carries a significant risk of graft-versus-host disease (GVHD) …
A Saad, M de Lima, S Anand, VR Bhatt… - Journal of the National …, 2020 - jnccn.org
Hematopoietic cell transplantation (HCT) involves the infusion of hematopoietic progenitor cells into patients with hematologic disorders with the goal of re-establishing normal …
RM Shapiro, JH Antin - Expert Review of Hematology, 2020 - Taylor & Francis
Introduction The traditional therapeutic modalities to manage SR-acute GVHD have focused on the inhibition of the alloreactive T-cell response, while in the setting of SR-chronic GVHD …
A Mancusi, S Piccinelli, A Velardi, A Pierini - Frontiers in immunology, 2018 - frontiersin.org
FoxP3+ regulatory T cells (Tregs) are a subset of CD4+ T cells that can suppress proliferation and effector functions of T cells, B cells, NK cells, and antigen-presenting cells …
X Li, SKP Lau, PCY Woo - Experimental Biology and …, 2020 - journals.sagepub.com
The revolutionary success of biologic agents in treating various malignant and autoimmune conditions has been met with increased risk of opportunistic infections due to perturbations …
L Laisne, B Neven, JH Dalle… - Pediatric Blood & …, 2020 - Wiley Online Library
Background We conducted a national multicenter retrospective study in France to evaluate the efficacy and tolerance of ruxolitinib in children with steroid‐refractory acute graft‐versus …